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Abstract
The incidence of hepatobiliary malignancies, and especially intrahepatic cholangiocarcinoma (ICC), for patients with
Wilson’s disease (WD), is very low, even for cirrhotic patients. A 44-year-old male was admitted to our department
for treatment of a liver tumor. He was diagnosed with WD at the age of 15. According to radiological findings, his
liver tumor was a suspected hepatocellular carcinoma (HCC) or a combined hepatocellular and cholangiocellular
carcinoma. A partial resection of liver segments 8 (S8) and 5 (S5) was subsequently performed due to the intraoperative
suspicion of intrahepatic metastasis at the surface of S5. Postoperative histology revealed that the resected portion of S8
contained an ICC; the removed S5 portion comprised a regenerative nodule with hemosiderosis. To date, the patient has
survived without tumor recurrence for more than 44 months following surgery. A survey of the literature, inclusive of
case reports, would suggest that surgical resection is the primary course of action for a WD patient with ICC, if
liver function can be preserved and curative resection performed.
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Background
Wilson’s disease (WD) is an autosomal recessive genetic
disorder that results in excessive copper accumulation in
the liver, brain, and other vital organs. This disorder
manifests clinically as liver damage, with neurological or
psychiatric symptoms. While copper overload plays a
critical role in the initial liver injury that eventually leads
to chronic inflammation and cirrhosis, its direct onco-
genic potential remains unknown and merits further in-
vestigation [1]. Curiously, the incidence of hepatobiliary
malignancies for individuals with Wilson’s disease is very
low, even in cirrhotic patients [2]; occasional cases of
hepatocellular carcinoma (HCC) have been reported,
with the incidence of intrahepatic cholangiocarcinoma
(ICC) rarer still. We now report such a case, which was
successfully resected, and discuss our conclusions with
reference to the current literature.
Case presentation
A 44-year-old male was admitted to our department for
treatment of a liver tumor. Abnormal liver function and
a subsequent blood test led to his diagnosis of WD at
the age of 15; his serum levels of ceruloplasmin were
barely detectable (≤20 mg/dL), with the urinary excre-
tion of copper at 209 μg/day (≥100 μg/day). A family
history showed that his sister had also been diagnosed
and treated for WD. Our patient had been treated with
D-penicillamine for 20 years. In the 20th year after his
diagnosis, magnetic resonance imaging (MRI) revealed a
solitary liver tumor, 1.8 cm in diameter, located in segment
8 (S8) of the liver. The results of laboratory examination,
including liver function, were as follows: serum aspartate
aminotransferase (AST) level, 87 IU/L; serum alanine ami-
notransferase (ALT) level, 115 IU/L; alkaline phosphatase
(ALP) level, 289 IU/L; γ-glutamyl transpeptidase (γ-GTP)
level, 909 IU/L; total bilirubin level, 0.5 mg/dL; pro-
thrombin time (PT) 78 s; albumin 3.9 g/dL; and indocy-
anine green retention 15 min (ICG-R15), 8 %. Tests for
hepatitis B surface antigen (HBs-Ag) and anti-hepatitis C
virus antibody (HCV-Ab) were negative. The serum level
of alpha-fetoprotein (AFP) was 37 ng/mL, and the serum
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levels of proteins induced by the absence of vitamin K
(PIVKA-II), CA19-9, and CEA were in the normal
range. Abdominal ultrasonography showed a hypoe-
choic lesion in S8 of the liver (Fig. 1a). By computed
tomography (CT), the tumor showed an early enhance-
ment (Fig. 1b), without a late washout pattern (Fig. 1c).
In gadolinium ethoxybenzyl diethylenetriaminepentaa-
cetic acid (Gd-EOB-EDTA)-enhanced MRI, the tumor
showed a low signal intensity in the hepatobiliary phase
(Fig. 1d, e). According to the radiological findings, our
preoperative diagnosis was a suspected HCC or a com-
bined hepatocellular and cholangiocellular carcinoma.
During a 3-h and 46-min operation, a non-anatomical
partial resection of S8 and S5 was completed because of
the suspicion of intrahepatic metastasis at the surface of
segment 5 (S5), which was detected as a 7-mm-sized
hypoechoic lesion in the intraoperative ultrasonography.
The gross appearance of liver was macro nodular cir-
rhosis, and its surface was irregular and its consistency
was firm. Intraoperative blood loss was 200 mL. Post-
operative histological examination revealed that the
resected S8 lesion was an ICC (Fig. 2a), with the S5 re-
section containing a regenerative nodule with hemosi-
derosis (Fig. 2b). The resected ICC was macroscopically
a whitish mass, with a clear boundary. Microscopically,
the tumor cells had formed glandular structures, which
led to a diagnosis of a moderately differentiated cholan-
giocellular carcinoma of the liver (Fig. 2c). While con-
firming a clean margin, the presence of pseudo-lobules
with fatty change in the adjacent non-cancerous por-
tion confirmed a diagnosis of liver cirrhosis (Fig. 2d, e).
We performed the rhodamine staining to evaluate the
accumulation of cooper in the non-cancerous liver, but
copper accumulation was little in the resected liver spe-
cimen. The patient was discharged from the hospital
without postoperative complications. At present, he is
alive, without disease recurrence, for more than 44 months
after his operation.
Discussion
Wilson’s disease is a hereditary disorder of copper me-
tabolism that results in the accumulation of copper in
the body, primarily in the liver, brain, and other vital or-
gans. Copper accumulation causes chronic liver damage
and leads to cirrhosis. Although chronic liver damage is
one of most important risk factors for the development
of primary liver cancer, its incidence seems to be rare
in WD. While the reasons for this low incidence re-
mains obscure, it has been suggested that excess copper
in the liver is protective against carcinogenesis, through
stabilization of cellular chromatin [3–5]. This conclu-
sion would appear to be at odds with a second report
Fig. 1 Preoperative radiological findings. a Abdominal ultrasonography showed a hypoechoic lesion in segment 8 (S8) of the liver. b The main tumor
(S8) showed an early enhancement in CT, which was prolonged until the delayed phase (c). d Gadolinium ethoxybenzyl diethylenetriaminepentaacetic
acid (Gd-EOB-EDTA)-enhanced MRI revealed a solitary 1.8-cm tumor, with a low-intensity signal in the hepatobiliary phase in the transverse (d)
and sagittal planes (e)
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showing that excess copper provokes DNA damage via
the generation of reactive oxygen species [6]. Clearly,
the relationship between WD and liver cancer remains
controversial [7, 8].
A multicenter cohort study of 1186 patients with WD
revealed that their incidence of primary liver cancer
was 0.28 per 1000 person years, with a prevalence of
1.2 %. The incidences of HCC and ICC for individuals
with WD are 0.7 and 0.5 %, respectively [2]. In contrast,
the rate of HCC development in patients who have
contracted the hepatitis C virus is 3.9 % per year; the
risk of primary liver cancer for individuals with WD is
therefore demonstrably low.
Intrahepatic cholangiocarcinoma (ICC) is the second
most common primary liver cancer [9], and has been
considered incurable, and rapidly lethal unless full
lesional resection can be achieved. The prognosis of
biliary tract cancer also remains poor [10]. Twelve cases
of ICC associated with WD have been reported in the
literature, including the present case study (Table 1);
six of these cases were from the Pfeiffenberger cohort
study [2], with a further three cases from Walshe’s
cohort study [11], although details for these cases were
not included. Of the two remaining reports [12, 13],
one described a patient undergoing liver transplant-
ation for WD, with a small nodule, which was treated
with four cycles of doxorubicin-based, transcatheter ar-
terial chemoembolization. The tumor was subsequently
diagnosed as an ICC in the explanted liver. Due to
recurrent ICC after liver transplantation, selective in-
ternal radiation therapy was performed followed by
right hemihepatectomy [12]. The final report described a
diagnosis of WD following a right hepatic lobectomy and
lymph node dissection, for a patient with WD [13]. In the
present case, the tumor was about 4 cm in diameter in
S8 of the liver. Histologic examination showed that the
tumor was a moderately differentiated cholangiocarci-
noma and that the non-cancerous liver was fibrotic,
with steatosis.
Five of the 12 cases, including ours, were treated with
surgical resection; all of these patients were alive at the
time of writing. Recently, the Mayo clinic reported that
liver transplantation following high-dose neoadjuvant
radiotherapy with chemosensitization achieved excel-
lent results for patients with early stage, unresectable
hilar cholangiocarcinoma or cholangiocarcinoma aris-
ing in the setting of primary sclerosing cholangitis [14].
Liver transplantation is reported as one of treatment
options for WD, for which there is an excellent long-
term outcome. However, liver failure associated with
WD remains a rare indication for liver transplantation
(less than 1 %).
Fig. 2 The resected specimens of S8 (a) and S5 (b). Histological examination of the resected specimens. c The lesion in S8 was a moderately
differentiated cholangiocarcinoma of the liver (HE staining, ×100). The adjacent, non-cancerous liver parenchyma demonstrated typical cirrhotic
features with steatosis (HE staining, ×40) (d), (HE staining, ×100) (e)
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Conclusions
In the present case, we performed a partial liver resection
for ICC; the patient has survived without tumor recurrence
in excess of 44 months following curative resection. Surgi-
cal resection would therefore seem to be the treatment of
choice for a WD patient with ICC, when liver function can
be preserved and curative resection performed.
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Table 1 Clinical characteristics of patients with Wilson’s disease
References Sex Age at tumor diagnosis Time until tumor detection
from diagnosis of WD (years)
Therapy for ICC Patient status
Walshe (2003) [11] F 28 15 – Not available
Walshe (2003) [11] F 40 24 – Not available
Walshe (2003) [11] F 85 22 – Not available
Saito (2009) [13] M 39 28 Right lobectomy Not available
Sperling (2014) [12] – 55 – Liver transplantation for primary tumor
(radiation and right hemihepatectomy
for recurrence)
48 months, alive
Pfeiffenberger (2015) [2] M 53 22 Orthotopic liver transplantation,
chemotherapy (GEM/CDDP)
26 months, dead
Pfeiffenberger (2015) [2] M 43 19 Chemotherapy (GEM) 12 months, dead
Pfeiffenberger (2015) [2] F 33 6 Chemotherapy (CDDP/GEM) lost for follow-up
Pfeiffenberger (2015) [2] M 72 41 Surgical resection Not available
Pfeiffenberger (2015) [2] M 56 7 RFA, chemotherapy (CDDP/GEM) 12 months, dead
Pfeiffenberger (2015) [2] F 70 41 Surgical resection Not available
Present case M 44 20 Surgical resection 44 months, alive
GEM gemcitabine, CDDP cisplatin
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